Video goggles help VA in amblyopia

Article

A video goggle-based technology may help increase visual acuity (VA) in children with amblyopia.

A video goggle-based technology called Reviview may help increase visual acuity (VA) in children with amblyopia. The technology is based on the principle that any video content can be transformed into a useful treatment tool for amblyopia.

According to co-inventors Ilan Vadai and Yuval Avni, Reviview incorporates brain stimulation technology designed to improve vision via a set of dedicated video goggles. To improve his or her visual acuity, a child wears the goggles to watch 30 to 60 minutes of their favourite animated television shows per day.

Vadai and Avni both have backgrounds in medical device design; Vadi also has a background in video production.

According to Vadai and Avni, in a study of 16 children aged 4 to 8 years who were provided with prototypes of the device, watching 30 to 60 minutes of their favourite animated television shows led to improvements in VA in 88% of the participants. Improvements after 4 weeks ranged from 1 LogMAR line up to 5 LogMAR lines. The average improvement was 2 lines (±1.7 lines) after 4 weeks and 2.6 lines (±1.5 lines) after 8 weeks.

"Adherence is a major problem with amblyopia treatment routines. With our approach, the fun of the treatment and the fast results contribute to the high level of commitment we see among kids and parents to our unique and patented treatment process," Vadai said.

He added that the goggles could be ready for marketing in about 12 months, and the company is looking for funding to finish the product design and conduct further studies.

For more information go to www.visiortech.com.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.